Lenvatinib for Advanced Bone and Soft Tissue Sarcoma

Clinical trial NCT05617859 · RECRUITING

Trial details

NCT number: NCT05617859
Sponsor: Henan Cancer Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Effectiveness Sexuality

Start date: 2023-04-30
Primary completion: 2026-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.